Matches in Nanopublications for { ?s ?p "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 17 of
17
with 100 items per page.
- NP20666.RA-wjXqFi28XcaGQiw4cCQz3VwEnMc615t3ncfgkzHmgc130_assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20666.RA-wjXqFi28XcaGQiw4cCQz3VwEnMc615t3ncfgkzHmgc130_provenance.
- NP20646.RAIJjOsxPM5U6Ik08YA2kLe9zdeTQYM57Y-PYADuEmUIY130_assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20646.RAIJjOsxPM5U6Ik08YA2kLe9zdeTQYM57Y-PYADuEmUIY130_provenance.
- NP20657.RAJxjDk0swDM9bj6ric7igaH99blF-SpbA6iHDdngg_Ak130_assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20657.RAJxjDk0swDM9bj6ric7igaH99blF-SpbA6iHDdngg_Ak130_provenance.
- NP19957.RAc6U5fImSAGcACPzraCn254fpQnL76Au6GZMsmC95tFQ130_assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19957.RAc6U5fImSAGcACPzraCn254fpQnL76Au6GZMsmC95tFQ130_provenance.
- NP19971.RAUKzOOZbzePokux76FciAtamU5ZgJXmikcgMgZMdzVcc130_assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19971.RAUKzOOZbzePokux76FciAtamU5ZgJXmikcgMgZMdzVcc130_provenance.
- assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP3954.RAYA4jLpUDGodYFrCwxNBX6IG1McjMmZuKxAPNAYZr9yY130_assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP3954.RAYA4jLpUDGodYFrCwxNBX6IG1McjMmZuKxAPNAYZr9yY130_provenance.
- NP15155.RATPZ07g0mYwZ5szJGOFtW-TWLJ1JO5oI-TRzgVif3Gzk130_assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP15155.RATPZ07g0mYwZ5szJGOFtW-TWLJ1JO5oI-TRzgVif3Gzk130_provenance.
- NP19961.RAGbPC1_99y-FmJQwgocRiX68w8dSl0s2J4InOVHS18sQ130_assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19961.RAGbPC1_99y-FmJQwgocRiX68w8dSl0s2J4InOVHS18sQ130_provenance.
- NP486338.RAoGOzbDNaPgRZdH-0WN0emNTHRyvI3QSrS9-qwRxftiI130_assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486338.RAoGOzbDNaPgRZdH-0WN0emNTHRyvI3QSrS9-qwRxftiI130_provenance.
- NP486340.RAqJMROV-84ryqyuUP25r5uDQmTyxItBgwQic0KRO1N_o130_assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486340.RAqJMROV-84ryqyuUP25r5uDQmTyxItBgwQic0KRO1N_o130_provenance.
- NP486337.RA2gUBBJRCty2YvuyqiFqQUAZzqL4ivMCJ8wZ-DyBIi_4130_assertion description "[A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486337.RA2gUBBJRCty2YvuyqiFqQUAZzqL4ivMCJ8wZ-DyBIi_4130_provenance.